Bausch Health Companies (BHC) Non-Current Deferred Tax Liability (2010 - 2026)

Bausch Health Companies (BHC) reported Non-Current Deferred Tax Liability of $179.0 million for Q1 2026, up 33.58% on a YoY basis from $134.0 million in Q1 2025, and up 21.77% sequentially from $147.0 million in Q4 2025.

Bausch Health Companies (BHC) Non-Current Deferred Tax Liability (2010 - 2026) Analysis & Trends

Bausch Health Companies (BHC) has 17 years of Non-Current Deferred Tax Liability data on file, last reported at $179.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Deferred Tax Liability rose 33.58% year-over-year to $179.0 million; the trailing twelve-month figure through Mar 2026 stood at $179.0 million (up 33.58% YoY), and the FY2025 full-year result was $147.0 million, up 14.84% from the prior year.
  • Non-Current Deferred Tax Liability rose to $179.0 million in Q1 2026, from $147.0 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $552.0 million in Q1 2022 to a low of $128.0 million in Q4 2024.
  • A 5-year average of $253.8 million and a median of $179.0 million in 2026 frame the typical range for Non-Current Deferred Tax Liability.
  • Across the five-year window, Non-Current Deferred Tax Liability sank 66.84% in 2024 and soared 33.58% in 2026, its largest moves.
  • Tracing BHC's Non-Current Deferred Tax Liability over 5 years: stood at $390.0 million in 2022, then retreated by 1.03% to $386.0 million in 2023, then sank by 66.84% to $128.0 million in 2024, then increased by 14.84% to $147.0 million in 2025, then climbed by 21.77% to $179.0 million in 2026.
  • Business Quant data shows BHC's Non-Current Deferred Tax Liability at $179.0 million in Q1 2026, $147.0 million in Q4 2025, and $145.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Bausch Health Companies 1.66 Bn 1.33 Bn 2.52 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 179.00 Mn
Mar 31, 2026 179.00 Mn
Dec 31, 2025 147.00 Mn
Dec 31, 2025 147.00 Mn
Sep 30, 2025 145.00 Mn
Sep 30, 2025 145.00 Mn
Jun 30, 2025 144.00 Mn
Jun 30, 2025 144.00 Mn
Mar 31, 2025 134.00 Mn
Mar 31, 2025 134.00 Mn
Dec 31, 2024 128.00 Mn
Dec 31, 2024 128.00 Mn
Sep 30, 2024 169.00 Mn
Sep 30, 2024 169.00 Mn
Jun 30, 2024 170.00 Mn
Jun 30, 2024 170.00 Mn
Mar 31, 2024 170.00 Mn
Mar 31, 2024 170.00 Mn
Dec 31, 2023 386.00 Mn
Dec 31, 2023 386.00 Mn